Physical AI for biology, built by scientists.

The judgment that decides whether an assay worked, why it failed, and what to run next has lived in scientists' heads and hands – tacit, and often not written. reinhaudt encodes that laboratory intelligence layer into autonomous execution, so biology runs at the scientist's bar: reproducibly, and at scale. That judgment can now be encoded by the domain experts who hold it.

The Laboratory Intelligence Layer

There's a layer missing from biology, and we've just reached the moment it can be built.

For decades, lab automation has given us better hands – faster pipetting, more throughput, robots that execute the steps you hand them. What it may not have given us is the mind: the judgment that decides whether an assay worked, why it failed, what to run next, when to trust a result and when to throw it out. That judgment – call it the laboratory intelligence layer – has often stayed human. It is a bottleneck in biological R&D, and a reason automation has underperformed.

That layer is tacit. It doesn't live in protocols or papers. It lives in the heads and hands of domain experts, built from years at the bench with valuable parts not fully articulated.

We've crossed an inflection point. LLMs can now drive clinical-grade lab hardware directly, and for perhaps the first time the person who holds the tacit knowledge can encode it themselves – training the robotics against their own standard, being both the builder and the benchmark, iterating until the machine performs on par with their own hands. The expert no longer has to translate their judgment through someone who doesn't share it. They build the intelligence layer directly, and the tacit becomes executable. I know, because I've done it: handed a full workflow to an agent and watched it run end to end, no one at the bench, at a quality better than by hand.

This is the moment. The time to encode expert judgment into autonomous execution is now – not because the robots finally exist, but because the experts can finally teach them.

Once that layer exists, the rest follows. Senior-scientist execution, reproducible, at scale. The cost of running biology collapses toward the cost of the chemistry itself. The scarce thing – expert time, human creativity – is freed for the work that matters: understanding nature, and engineering it for good.

The hardware is here. The models are here. The thing missing was the intelligence layer – and the only people who can build it are the ones who already hold it.

Where the Robots Fail – and What I Teach Them

The claim: the laboratory intelligence layer is tacit, and the person who holds it can encode it directly. Here's the specific version – the work, where automation breaks, and how the tacit becomes transferable.

A redacted workflow

Take a low-input epigenome workflow – reading chromatin state from vanishingly small amounts of material, at a sensitivity that gives a direct readout of epigenetic reprogramming.

Consider a measurement layer that stays challenging even for the reprogramming and longevity field. The recent, celebrated result where AI-designed factors sharply raised reprogramming-marker expression was validated by markers, morphology, DNA-damage repair, and karyotype – the functional consequences. The direct epigenetic state, the substrate being reprogrammed, is the harder readout. It goes missing for a plain reason: it's a tacit skill, hard to staff for.

That readout is what I build. It's hard by hand even for an expert; teaching a robot to do it at the scientist's bar is the real work – not "automate a kit," but recapitulate a technique few labs run at all.

Where the robots fail, and why

Here's the part that isn't in the protocol. At low input there's little margin, and passing QC or not often comes down to calls made by feel:

• pipetting height – relative to the meniscus and the well bottom; too high shears or splashes, too low misses or scrapes
• blowout volume, and the timing of it
• aspiration and dispense speed – different for a viscous mix, a bead slurry, or a fragile low-volume sample
• the dip, the touch-off, the swirl, the mix pattern
• timing, and on-ice vs. room-temperature handling at the right step
• real-time volume adjustments – adapting to input constraints per step
• sample-type-dependent chemistry updates

Little of this is written down – I didn't write it down myself, and a camera may not catch it. Yet it's often what clears a senior scientist's bar. It's why lab automation may run the steps faithfully and still get worse data: the steps that mattered weren't on the page. The one making the call is the one who can encode them.

How you encode it: instrument the delta

A manual gives you the official protocol, not the real one. The real one comes from instrumenting the gap: run the standard protocol, run it my way, measure both the same, and let the decision rule fall out of the deviations that improve the data. The scientist is both builder and benchmark – a controlled study of my own technique, pointed inward. That's how "I get good data" becomes "the platform does."

Why this is the moat

The reason this is hard is the reason it's defensible. Hand someone the protocol and the output, and they'd still struggle to reproduce the data – because the part that makes it work isn't in the artifact. It's in the hands.

That non-transferability is likely biology's moat; I think of it as the problem: it's why a great scientist can be a single point of failure, why the knowledge leaves when they do, why programs are difficult to scale past a few pairs of hands. So the moat isn't the protocol. It's the judgment behind it – and judgment can now be encoded.